According to Hanmi Pharmaceutical 's latest financial reports the company's current EPS (TTM) is $0.98. In 2022 the company made an earnings per share (EPS) of $0.78 an increase over its 2021 EPS that were of $0.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.98 | 26.4% |
2022 | $0.78 | 46.4% |
2021 | $0.53 | 86.13% |
2020 | $0.28 | -24.72% |
2019 | $0.38 | 56.55% |
2018 | $0.24 | -38.79% |
2017 | $0.39 | 212.43% |
2016 | $0.13 | -94.43% |
2015 | $2.27 | 684.43% |
2014 | $0.29 | 133.1% |
2013 | $0.12 | -23.84% |
2012 | $0.16 | -184.03% |
2011 | -$0.19 | -154.8% |
2010 | $0.35 | -86.77% |
2009 | $2.67 | -34.09% |
2008 | $4.06 | 8.62% |
2007 | $3.73 |